GlassScriptPhysician profile
Stephen A Olenchock
NPI 1003866781
$29,416.71
in general payments reported to CMS, 2019-2025
7 companies · $1,161 in 2025
The $1,161 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,909 · 2020: $2,219 · 2021: $2,648 · 2022: $2,943 · 2023: $11K · 2024: $7,065 · 2025: $1,161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,480 · Travel and Lodging: $6,560 · Food and Beverage: $4,658.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,480.00 |
| Travel and Lodging | $6,559.83 |
| Food and Beverage | $4,658.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $25,209.06 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Evoque, Sapien 3 Ultra Resilia |
| Novus Surgical Consultants | $2,036.19 | 2024 | |
| Siemens Medical Solutions USA, INC. | $1,543.54 | 2023-2024 | Artis Pheno |
| Arthrex, INC. | $429.71 | 2024 | |
| Medtronic Vascular, INC. | $152.02 | 2019 | |
| Csl Behring | $25.63 | 2020 | |
| Teleflex LLC | $20.56 | 2024 | Manta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Olenchock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.